<DOC>
	<DOCNO>NCT03077919</DOCNO>
	<brief_summary>This multisite , randomize , blind , sham-procedure-controlled study evaluate efficacy right-sided stellate ganglion block ( SGB ) acute symptomatology Post traumatic Stress Disorder ( PTSD ) , evaluate Clinician-Administered PTSD Scale ( CAPS-5 ) clinical interview pre-treatment 8 week . This entry describe effectiveness study.The acceptability study describe separate entry .</brief_summary>
	<brief_title>Effectiveness Acceptability Stellate Ganglion Block Posttraumatic Stress Disorder Symptoms - Effectiveness</brief_title>
	<detailed_description>Study intervention administer week 0 week 2 . Injections perform ultrasound visualization . The study medication either 7-10 mL 0.5 % ropivacaine inject ventral right longus coli muscle ( around ventral fascia ) longus coli immediately dorsal presumed ventral fascia level C6 anterior tubercle ( landmarks stellate ganglion ) ( active study medication ) 1-2 mL preservative free normal saline inject anterolateral anterior tubercle C6 ( sham procedure ) . The participant inform treatment receive interaction participant treat physician script much possible . Following intervention , treat physician contact participant except require participant safety . Participants evaluate posttraumatic stress disorder ( PTSD ) symptomatology prior week 0 8 week use Diagnostic Statistical Manual ( DSM-5 ) Clinician-Administered PTSD Scale ( CAPS-5 ) . They complete PTSD Checklist DSM-5 ( PCL-5 ) , PTSD Checklist - Civilian Version ( PCL-C ) , Mini-international Neuropsychiatric Interview ( M.I.N.I.-Plus ) Suicidality Items 0 , 2 , 4 , 6 , 8 week ; also complete M.I.N.I.-Plus item screen . The 12 item short form survey ( SF-12 ) , generalize anxiety disorder 7-item ( GAD-7 ) , patient health questionnaire ( PHQ-9 ) , K6 , Alcohol Use Disorder Identification Test ( AUDIT-C/AUDIT ) , short pain scale complete week 0 , 4 , 8 .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>Member Army active duty status Personal access Internet Anticipated stable assignment installation least 2 month Stable dose â‰¥3 month , receive psychotropic medication Prior enrollment , offer PTSD treatment use Alevel modality ( defined U.S. Army Medical Command ( MEDCOM ) policy 14094 ; 18 Dec 2014 ) . PTSD Checklist Civilian ( PCLC ) score 32 great screen Acceptable clinically indicated preoperative laboratory study , per standard sitespecific protocols Prior Stellate Ganglion Block ( SGB ) Allergy amide local anesthetic ( e.g. , ropivacaine , bupivacaine ) Pregnancy ( evaluate urine test preprocedure ) Current anticoagulant use History bleeding disorder Infection mass injection site Myocardial infarction within 6 month procedure Phrenic laryngeal nerve palsy ( hoarseness ) History glaucoma History schizophrenia , psychotic disorder , bipolar disorder , personality disorder ( axis 2 ) Moderate severe traumatic brain injury Symptoms moderate severe substance use disorder past 30 day Suicidal ideation past 2 month , document M.I.N.I.Plus Suicidality Items Any ongoing major life stressor condition list site Investigator believe clearly would place participant risk injury poor outcome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Posttraumatic Stress Disorder</keyword>
	<keyword>Generalized Anxiety Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Distress</keyword>
	<keyword>Alcohol Use</keyword>
	<keyword>Pain</keyword>
</DOC>